Pediatric Meeting Agenda

**Speakers, Times, and Schedule are subject to change**
9:00 AM - 4:00 PM US Eastern Time Daily

READ SPEAKER BIOS

REGISTER NOW!

DAY 1 - November 2nd 2021

Session  
Keynote - Big Pharma CMO
(Speaker to be confirmed)
 

Challenges Faced in Pediatric Drug Administration - In-Patient Settings (working title)
Louise Bracken, Co-Director Paediatric Medicines Research Unit, Alder Hey Children’s NHS Foundation Trust

LBracken
Co-administration of Pediatric Medicines with Food and Drinks
Nikoletta Fotaki, Reader in BiopharmaceuticsUniversity of Bath
 
NFotaki
BREAK  

Developing ZENEO® Needle-free Auto-injector for Pediatric Use
Olivier Giré, Chief Operating Officer Specialty Pharma, Crossject
Donald Zinn, Vice President US Business, Crossject USA Inc
Henri Bodeau, Crossject

 OGire  DZinn
 
Pediatric Pharmaceutics
Catherine Tuleu, Professor in Pediatric Pharmaceutics, University College London School of Pharmacy
CTuleu

A Matter of Taste: Development of Palatable Paediatric Dosage Forms
David Clapham, Independent Pharmaceutical Consultant

David Clapham
LUNCH  
Chemistry, Manufacturing, and Controls: Industry Perspective:
Title to be Confirmed
Stuart Charlton, Associate Scientific Director, Bristol Myers Squibb
SCharlton
Minitabs
Ron Smith, Principal, Pharmawyze, LLC
RSmith

Chemistry, Manufacturing, and Controls: Multiparticulates
(Speaker to be confirmed)

 
BREAK  
Excipient Selection for Pediatric Drug Products
Kevin Hughes, Regulatory Affairs and QA Manager, Colorcon Ltd.
KHughes

The Phillips-Medisize Mini-tablet Dispenser
Bjørn Knud Andersen, Director Front-End Innovation, Phillips-Medisize
Henrik Leisner

BKAndersen

 
Clinical: Clinical Perspectives on Pediatric Development
(Speaker to be confirmed)
 

DAY 2 - November 3rd 2021

Session  
Keynote - 
(Speaker to be confirmed)
 
From the Front Line: Challenges in Pediatric Drug Administration
(Speaker to be confirmed)
 

Moxidectin Pediatric Formulation Development
Nicky Konstantopoulos, Associate Director, CMC, Medicines Development for Global Health

 
BREAK  

Insights and Lessons from the Development of Alkindi
Helen Coope, European Medical Affairs Manager, Diurnal

Helen Coope

Design and Delivery of Paediatric Early Phase Clinical Trials - Learning from 10 years of Alder Hey Clinical Research Facility
Dan Hawcutt, Senior Lecturer Paediatric Clinical Pharmacology, University of Liverpool

DHawcutt

Development and Characterization of Pediatric Formulations
Kingsley Iyoha, Director, Development, Pharmaceutical Sciences, Quotient Sciences

KIyoha
LUNCH  

MicroCoatTM – Production of versatile micropellets for pediatric applications
Fang Liu, Founder & Director, Fluid Pharma

FLiu
Chemistry, Manufacturing, and Controls: Industry Talk
(Speaker to be confirmed)
 
Overview of EU and FDA Pediatric Regulations
Gloria Garcia Palacios, Global Regulatory Affairs - EU Head I&I, Sanofi
Gloria Garcia
BREAK  
Gene Therapy (working title)
Ahad Rahim, University College London
 
Chemistry, Manufacturing, and Controls: Taste Assessment and Food Compatibility
(Speaker to be confirmed)
 
Devices:
(Speaker to be confirmed)